SCHEMBL995182

SCHEMBL995182

CCCCC(Oc1ccccc1Cl)N1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
TSHR P16473 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTR7 P34969 3/20 0.39
HTR6 P50406 3/20 0.39
POLB P06746 1/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
HRH3 Q9Y5N1 2/20 0.37
DRD2 P14416 2/20 0.37
HTR2A P28223 2/20 0.37
SLC6A2 P23975 2/20 0.36
SLC6A3 Q01959 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL991525 0.89 HTR7 (0.47) L3MBTL1CYP1A2CYP2D6CYP2C19KMT2A
SCHEMBL991769 0.88 HTR7 (0.39) L3MBTL1CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL11539874 0.85 TSHR (0.44) L3MBTL1CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL11538270 0.84 TSHR (0.47) L3MBTL1CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL12130571 0.81 TDP1 (0.45) MEN1KMT2AHTR7HTR6HRH3
SCHEMBL995782 0.80 LTA4H (0.40) CYP1A2CYP2D6CYP2C19ALDH1A1HRH3
SCHEMBL12130553 0.80 SLC6A2 (0.42) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL12130449 0.78 HRH3 (0.43) CYP1A2CYP2D6CYP2C19TSHRPOLB
SCHEMBL12130554 0.78 HRH3 (0.43) CYP1A2CYP2D6CYP2C19TSHRPOLB
SCHEMBL992649 0.77 HRH3 (0.40) TSHRHRH3SLC6A2SLC6A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011008666-A2 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS THERAVANCE, INC. (US) 2011-01-20 WO disclosed